New implant could help people stay off opioids for months
Disease control
Not yet recruiting
This study tests the safety of a long-acting naltrexone implant (OLANI) in 250 adults with opioid use disorder who want to prevent relapse. The implant releases medication over several months to block the effects of opioids, helping patients focus on recovery. Participants will r…
Phase: PHASE2 • Sponsor: Go Medical Industries Pty Ltd • Aim: Disease control
Last updated May 08, 2026 12:01 UTC